CoChat

In silico design and validation of a time-varying PID controller for an artificial pancreas with intraperitoneal insulin delivery and glucose sensing

Open access
Dalla Libera, Alberto, Toffanin, Chiara, Drecogna, Martina, Galderisi, Alfonso, Pillonetto, Gianluigi, Cobelli, Claudio · 2023 · APL Bioengineering

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

Type 1 diabetes (T1D) is a chronic autoimmune disease featured by the loss of beta cell function and the need for lifetime insulin replacement. Over the recent decade, the use of automated insulin delivery systems (AID) has shifted the paradigm of treatment: the availability of continuous subcutaneous (SC) glucose sensors to guide SC insulin delivery through a control algorithm has allowed, for the first time, to reduce the daily burden of the disease as well as to abate the risk for hypoglycemia. AID use is still limited by individual acceptance, local availability, coverage, and expertise. A major drawback of SC insulin delivery is the need for meal announcement and the peripheral hyperinsulinemia that, over time, contributes to macrovascular complications. Inpatient trials using intraperitoneal (IP) insulin pumps have demonstrated that glycemic control can be improved without meal announcement due to the faster insulin delivery through the peritoneal space. This calls for novel control algorithms able to account for the specificities of IP insulin kinetics. Recently, our group described a two-compartment model of IP insulin kinetics demonstrating that the peritoneal space acts as a virtual compartment and IP insulin delivery is virtually intraportal (intrahepatic), thus closely mimicking the physiology of insulin secretion. The FDA-accepted T1D simulator for SC insulin delivery and sensing has been updated for IP insulin delivery and sensing. Herein, we design and validate—in silico—a time-varying proportional integrative derivative controller to guide IP insulin delivery in a fully closed-loop mode without meal announcement.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1063/5.0145446

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Upper panel: schematic diagram of the T1D pathophysiology; the β-cells of the pancreas are not working. Bottom panel: schematic diagram of the T1D therapy; both SC and IP delivery modes are depicted.
FIG. 1. Upper panel: schematic diagram of the T1D pathophysiology; the β-cells of the pancreas are not working. Bottom panel: schematic diagram of the T1D therapy; both SC and IP delivery modes are depicted.CC BY · PubMed Central
FIG. 2. Distributions of the 100 TF gain (left) and 300 poles (right).
FIG. 2. Distributions of the 100 TF gain (left) and 300 poles (right).CC BY · PubMed Central
FIG. 3. Example of the piecewise-constant CR and filtered CR as a function of time of day.
FIG. 3. Example of the piecewise-constant CR and filtered CR as a function of time of day.CC BY · PubMed Central
FIG. 4. Average time evolution of the glucose and insulin (median and confidence intervals) obtained with the PID controller based on TDI and CR personalizations in the standard setup.
FIG. 4. Average time evolution of the glucose and insulin (median and confidence intervals) obtained with the PID controller based on TDI and CR personalizations in the standard setup.CC BY · PubMed Central
FIG. 5. Average time evolution of the glucose and insulin (median and confidence intervals) obtained with the PID controller based on TDI and CR personalizations in the robust setup.
FIG. 5. Average time evolution of the glucose and insulin (median and confidence intervals) obtained with the PID controller based on TDI and CR personalizations in the robust setup.CC BY · PubMed Central
FIG. 6. Schematic representation of the IP-IP AP simulator. The insulin subsystem is evidenced in red.
FIG. 6. Schematic representation of the IP-IP AP simulator. The insulin subsystem is evidenced in red.CC BY · PubMed Central
FIG. 7. Example of the actual, measured, and filtered glucose concentration time course.
FIG. 7. Example of the actual, measured, and filtered glucose concentration time course.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

Metadata

Authors
Dalla Libera, A., Toffanin, C., Drecogna, M., Galderisi, A., Pillonetto, G., & Cobelli, C.
Affiliations
  • Department of Woman and Child's Health, University of Padova 1 , 35128 Padova, Italy
  • University of Pavia (IT)
  • University of Padua (IT)
Corresponding author
Cobelli, Claudio
Venue
APL Bioengineering
Published
2023-05-23
Volume
7
Issue
2
Pages
026105-026105
ISSN
2473-2877 (ISSN-L)
OpenAlex
W4377292347
Cited by
8
References
26
Citations by year
2026: 1 · 2025: 4 · 2024: 2 · 2023: 1
FWCI
1.64
Type
journal article
Language
en
Open access
Licence
Locations
  • APL Bioengineering (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Padua Research Archive (University of Padova) (submittedVersion)
Funders
European Commission (FORGETDIABETES-FET-EU951933)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
type 1 diabetes, artificial pancreas, glucose detection, hypoglycemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.